We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
NICE has published draft guidance which recommends Ocaliva, also known as obeticholic acid, for people with the chronic liver disease known as primary biliary cholangitis (PBC).